findmyKOL
Clinical trialNCT00487799WithdrawnPhase 1Interventional

A Study of Ularitide in the Treatment of Subjects With Acute Decompensated Heart Failure

SponsorFacet BiotechEnrollment32Heart Failure, Congestive
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

To determine the maximum tolerated dose (MTD) of ularitide in the treatment of subjects hospitalized with symptomatic acute decompensated heart failure (ADHF).

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Ucsd Medical Center

    San Diego, California, United States

  • the Atlanta Cardiology Group, Pc

    Atlanta, Georgia, United States

  • Feinberg School of Medicine, Northwestern Univ.

    Chicago, Illinois, United States

  • Henry Ford Health System

    Detroit, Michigan, United States

  • Washington University School of Medicine

    St Louis, Missouri, United States

  • Cardiovascular Specialists Pc Dba New York Heart Ctr.

    Syracuse, New York, United States

  • Albert Einstein Medical Center

    Philadelphia, Pennsylvania, United States

  • Kore Cardiovascular Research Institute

    Lexington, Tennessee, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Ularitide
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
—
Primary completion
—
Completion
—
Last update posted
20 Jul 2009
Registered enrollment
32
Registry id
NCT00487799

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.